Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Clinical trial NCT06699849 · RECRUITING
Trial details
- NCT number
- NCT06699849
- Sponsor
- CSL Behring
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-07
- Primary completion
- 2027-10-22
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.